1887

Abstract

We modified the capsid protein of a human enterovirus 71 (HEV71) belonging to subgenogroup C4 (HEV71-C4) to generate a mouse virulent strain, based on the genetic information derived from our previous subgenogroup B3 mouse-adapted virus. Infectious clone-derived mutant virus populations containing the capsid protein mutations VP1-Q145E and VP1-Q145G were generated by site-directed mutagenesis of an infectious clone of a subgenogroup C4 strain. Viruses expressing the VP1-Q145E were virulent in 5-day-old BALB/c mice with 100 % mortality rate observed. Skeletal muscle appears to be the primary site of replication of this virus with limb muscle showing severe myositis. Virus was also isolated from spleen, liver, heart and brain of infected mice. This study demonstrates that introducing a key mutation into the HEV71 VP1 capsid protein is able to generate a mouse virulent HEV71 strain from a different genogroup as well as providing an alternative strategy for the generation of mouse virulent HEV71.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.043893-0
2012-09-01
2019-09-17
Loading full text...

Full text loading...

/deliver/fulltext/jgv/93/9/1935.html?itemId=/content/journal/jgv/10.1099/vir.0.043893-0&mimeType=html&fmt=ahah

References

  1. Arita M., Shimizu H., Nagata N., Ami Y., Suzaki Y., Sata T., Iwasaki T., Miyamura T.. ( 2005;). Temperature-sensitive mutants of enterovirus 71 show attenuation in cynomolgus monkeys. . J Gen Virol 86:, 1391–1401. [CrossRef][PubMed]
    [Google Scholar]
  2. Arita M., Nagata N., Iwata N., Ami Y., Suzaki Y., Mizuta K., Iwasaki T., Sata T., Wakita T., Shimizu H.. ( 2007;). An attenuated strain of enterovirus 71 belonging to genotype a showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys. . J Virol 81:, 9386–9395. [CrossRef][PubMed]
    [Google Scholar]
  3. Bek E. J., Hussain K. M., Phuektes P., Kok C. C., Gao Q., Cai F., Gao Z., McMinn P. C.. ( 2011;). Formalin-inactivated vaccine provokes cross-protective immunity in a mouse model of human enterovirus 71 infection. . Vaccine 29:, 4829–4838. [CrossRef][PubMed]
    [Google Scholar]
  4. Chen Y. C., Yu C. K., Wang Y. F., Liu C. C., Su I. J., Lei H. Y.. ( 2004;). A murine oral enterovirus 71 infection model with central nervous system involvement. . J Gen Virol 85:, 69–77. [CrossRef][PubMed]
    [Google Scholar]
  5. Chua B. H., Phuektes P., Sanders S. A., Nicholls P. K., McMinn P. C.. ( 2008;). The molecular basis of mouse adaptation by human enterovirus 71. . J Gen Virol 89:, 1622–1632. [CrossRef][PubMed]
    [Google Scholar]
  6. Hashimoto I., Hagiwara A.. ( 1982;). Pathogenicity of a poliomyelitis-like disease in monkeys infected orally with enterovirus 71: a model for human infection. . Neuropathol Appl Neurobiol 8:, 149–156. [CrossRef][PubMed]
    [Google Scholar]
  7. Huang S. W., Hsu Y. W., Smith D. J., Kiang D., Tsai H. P., Lin K. H., Wang S. M., Liu C. C., Su I. J., Wang J. R.. ( 2009;). Reemergence of enterovirus 71 in 2008 in Taiwan: dynamics of genetic and antigenic evolution from 1998 to 2008. . J Clin Microbiol 47:, 3653–3662. [CrossRef][PubMed]
    [Google Scholar]
  8. Huang S. W., Wang Y. F., Yu C. K., Su I. J., Wang J. R.. ( 2012;). Mutations in VP2 and VP1 capsid proteins increase infectivity and mouse lethality of enterovirus 71 by virus binding and RNA accumulation enhancement. . Virology 422:, 132–143. [CrossRef][PubMed]
    [Google Scholar]
  9. Li Y. P., Liang Z. L., Gao Q., Huang L. R., Mao Q. Y., Wen S. Q., Liu Y., Yin W. D., Li R. C., Wang J. Z.. ( 2012;). Safety and immunogenicity of a novel human enterovirus 71 (EV71) vaccine: a randomized, placebo-controlled, double-blind, phase I clinical trial. . Vaccine 30:, 3295–3303. [CrossRef][PubMed]
    [Google Scholar]
  10. Ong K. C., Badmanathan M., Devi S., Leong K. L., Cardosa M. J., Wong K. T.. ( 2008;). Pathologic characterization of a murine model of human enterovirus 71 encephalomyelitis. . J Neuropathol Exp Neurol 67:, 532–542. [CrossRef][PubMed]
    [Google Scholar]
  11. Reed L. J., Muench H.. ( 1938;). A simple method of estimating fifty percent endpoints. . Am J Hyg 27:, 493–497.
    [Google Scholar]
  12. Schmidt N. J., Lennette E. H., Ho H. H.. ( 1974;). An apparently new enterovirus isolated from patients with disease of the central nervous system. . J Infect Dis 129:, 304–309. [CrossRef][PubMed]
    [Google Scholar]
  13. Tu P. V., Thao N. T. T., Perera D., Truong K. H., Tien N. T. K., Thuong T. C., How O. M., Cardosa M. J., McMinn P. C.. ( 2007;). Epidemiologic and virologic investigation of hand, foot, and mouth disease, southern Vietnam, 2005. . Emerg Infect Dis 13:, 1733–1741. [CrossRef][PubMed]
    [Google Scholar]
  14. Wang J. R., Tuan Y. C., Tsai H. P., Yan J. J., Liu C. C., Su I. J.. ( 2002;). Change of major genotype of enterovirus 71 in outbreaks of hand-foot-and-mouth disease in Taiwan between 1998 and 2000. . J Clin Microbiol 40:, 10–15. [CrossRef][PubMed]
    [Google Scholar]
  15. Wang Y. F., Chou C. T., Lei H. Y., Liu C. C., Wang S. M., Yan J. J., Su I. J., Wang J. R., Yeh T. M.. & other authors ( 2004;). A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. . J Virol 78:, 7916–7924. [CrossRef][PubMed]
    [Google Scholar]
  16. Wang W., Duo J., Liu J., Ma C., Zhang L., Wei Q., Qin C.. ( 2011;). A mouse muscle-adapted enterovirus 71 strain with increased virulence in mice. . Microbes Infect 13:, 862–870. [CrossRef][PubMed]
    [Google Scholar]
  17. Wang X., Peng W., Ren J., Hu Z., Xu J., Lou Z., Li X., Yin W., Shen X.. & other authors ( 2012;). A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71. . Nat Struct Mol Biol 19:, 424–429. [CrossRef][PubMed]
    [Google Scholar]
  18. Wright A. J., Phillpotts R. J.. ( 1998;). Humane endpoints are an objective measure of morbidity in Venezuelan encephalomyelitis virus infection of mice. . Arch Virol 143:, 1155–1162. [CrossRef][PubMed]
    [Google Scholar]
  19. Wu C. N., Lin Y. C., Fann C., Liao N. S., Shih S. R., Ho M. S.. ( 2001;). Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. . Vaccine 20:, 895–904. [CrossRef][PubMed]
    [Google Scholar]
  20. Zaini Z., Phuektes P., McMinn P.. ( 2012;). A reverse genetic study of the adaptation of human enterovirus 71 to growth in Chinese hamster ovary cell cultures. . Virus Res 165:, 151–156. [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.043893-0
Loading
/content/journal/jgv/10.1099/vir.0.043893-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error